Dennis R. Delaney’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.34M | Hold |
15,342
| – | – | 1.18% | 30 |
|
|
2025
Q4 | $3.51M | Hold |
15,342
| – | – | 1.76% | 22 |
|
|
2025
Q3 | $3.55M | Hold |
15,342
| – | – | 1.78% | 23 |
|
|
2025
Q2 | $2.85M | Hold |
15,342
| – | – | 1.46% | 26 |
|
|
2025
Q1 | $3.21M | Sell |
15,342
-20
| -0.1% | -$3.89K | 1.75% | 27 |
|
|
2024
Q4 | $2.73M | Hold |
15,362
| – | – | 1.44% | 28 |
|
|
2024
Q3 | $3.03M | Sell |
15,362
-50
| -0.3% | -$9.33K | 1.57% | 27 |
|
|
2024
Q2 | $2.64M | Hold |
15,412
| – | – | 1.43% | 27 |
|
|
2024
Q1 | $2.81M | Hold |
15,412
| – | – | 1.53% | 28 |
|
|
2023
Q4 | $2.39M | Sell |
15,412
-40
| -0.3% | -$5.83K | 1.42% | 29 |
|
|
2023
Q3 | $2.3M | Sell |
15,452
-40
| -0.3% | -$5.87K | 1.48% | 29 |
|
|
2023
Q2 | $2.09M | Buy |
15,492
+4,692
| +43% | +$688K | 1.27% | 31 |
|
|
2023
Q1 | $1.72M | Buy |
10,800
+400
| +4% | +$61.2K | 1.47% | 29 |
|
|
2022
Q4 | $1.68M | Hold |
10,400
| – | – | 1.5% | 27 |
|
|
2022
Q3 | $1.4M | Buy |
+10,400
| New | +$1.49M | 1.34% | 29 |
|
|
2020
Q2 | $1.27M | Sell |
12,950
-200
| -2% | -$17.6K | 1.7% | 26 |
|
|
2020
Q1 | $1M | Sell |
13,150
-100
| -0.8% | -$8.52K | 1.57% | 29 |
|
|
2019
Q4 | $1.17M | Hold |
13,250
| – | – | 1.5% | 29 |
|
|
2019
Q3 | $1M | Hold |
13,250
| – | – | 1.36% | 31 |
|
|
2019
Q2 | $964K | Sell |
13,250
-250
| -2% | -$19.6K | 1.29% | 32 |
|
|
2019
Q1 | $1.09M | Sell |
13,500
-250
| -2% | -$20.5K | 1.47% | 27 |
|
|
2018
Q4 | $1.27M | Hold |
13,750
| – | – | 1.96% | 24 |
|
|
2018
Q3 | $1.3M | Sell |
13,750
-1,750
| -11% | -$166K | 1.69% | 25 |
|
|
2018
Q2 | $1.44M | Sell |
15,500
-1,425
| -8% | -$139K | 2.06% | 22 |
|
|
2018
Q1 | $1.6M | Sell |
16,925
-410
| -2% | -$45K | 2.25% | 19 |
|
|
2017
Q4 | $1.68M | Sell |
17,335
-2,275
| -12% | -$214K | 2.24% | 19 |
|
|
2017
Q3 | $1.74M | Hold |
19,610
| – | – | 3.38% | 11 |
|
|
2017
Q2 | $1.42M | Sell |
19,610
-500
| -2% | -$33.6K | 2.87% | 15 |
|
|
2017
Q1 | $1.31M | Sell |
20,110
-220
| -1% | -$13.8K | 2.74% | 15 |
|
|
2016
Q4 | $1.27M | Sell |
20,330
-450
| -2% | -$27.5K | 2.73% | 14 |
|
|
2016
Q3 | $1.31M | Hold |
20,780
| – | – | 2.79% | 15 |
|
|
2016
Q2 | $1.29M | Hold |
20,780
| – | – | 2.75% | 14 |
|
|
2016
Q1 | $1.19M | Sell |
20,780
-300
| -1% | -$16.7K | 2.57% | 16 |
|
|
2015
Q4 | $1.25M | Buy |
+21,080
| New | +$1.21M | 2.79% | 15 |
|
Other funds holding ABBV
VCM
VPM
Dennis R. Delaney's ABBV Position: Q1 2026 in Review
Dennis R. Delaney held its AbbVie (ABBV) position steady in Q1 2026 at 15,342 shares worth $3.34M. The position accounts for 1.18% of the portfolio, ranked #30.
Dennis R. Delaney first reported a position in ABBV in Q4 2015 and has held it in 34 quarters since. The position peaked at $3.55M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Dennis R. Delaney held 15,342 shares of AbbVie worth $3.34M as of Q1 2026.
- Dennis R. Delaney left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 1.18% of Dennis R. Delaney's portfolio in Q1 2026, its #30 holding.
- Dennis R. Delaney first reported a position in AbbVie in Q4 2015 and has held it in 34 quarters since.
- Dennis R. Delaney's AbbVie position peaked at $3.55M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Dennis R. Delaney's 13F filing for Q1 2026, filed 14 May 2026.